Join
Live feed
·
PRReleasevia Quantisnow
Sanofi logo

Sanofi and pCPA Sign Letter of Intent for Dupixent® Across Four Indications in Dermatology and Respiratory Care

ByQuantisnow·Wall Street's wire, on your screen.
SNY· Sanofi
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNY (Sanofi) and more on Quantisnow.